Dcf Advisers, LLC Abb Vie Inc. Transaction History

Dcf Advisers, LLC

$242 Million
Q3 2024

A detailed history of Dcf Advisers, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Dcf Advisers, LLC holds 31,000 shares of ABBV stock, worth $5.44 Million. This represents 2.53% of its overall portfolio holdings.

Number of Shares

31,000

Previous 31,800 2.52%

Holding current value

$5.44 Million

Previous $5.45 Million 12.23%

% of portfolio

2.53%

Previous 2.95%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$163.84 - $199.33 $131,072 - $159,464	-800 Reduced 2.52%	31,000 $6.12 Million
Q1 2024 May 15, 2024	SELL	$159.82 - $182.1 $111,874 - $127,470	-700 Reduced 2.15%	31,800 $5.79 Million
Q4 2023 Feb 13, 2024	SELL	$137.6 - $154.97 $1.65 Million - $1.86 Million	-12,000 Reduced 26.97%	32,500 $5.04 Million
Q3 2023 Nov 13, 2023	SELL	$133.59 - $154.65 $407,449 - $471,682	-3,050 Reduced 6.41%	44,500 $6.63 Million
Q2 2023 Aug 09, 2023	SELL	$132.51 - $164.9 $3.24 Million - $4.03 Million	-24,450 Reduced 33.96%	47,550 $6.41 Million
Q4 2022 Feb 13, 2023	SELL	$138.31 - $165.87 $567,071 - $680,067	-4,100 Reduced 5.39%	72,000 $11.6 Million
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $134,210 - $153,930	1,000 Added 1.33%	76,100 $10.2 Million
Q2 2022 Aug 11, 2022	SELL	$137.62 - $174.96 $1.88 Million - $2.39 Million	-13,650 Reduced 15.38%	75,100 $11.5 Million
Q1 2022 May 13, 2022	SELL	$131.98 - $163.75 $1.39 Million - $1.73 Million	-10,568 Reduced 10.64%	88,750 $14.4 Million
Q4 2021 Feb 10, 2022	BUY	$107.43 - $135.93 $2.32 Million - $2.93 Million	21,568 Added 27.74%	99,318 $13.4 Million
Q3 2021 Nov 15, 2021	BUY	$106.4 - $120.78 $79,800 - $90,585	750 Added 0.97%	77,750 $8.39 Million
Q2 2021 Aug 13, 2021	SELL	$105.21 - $117.21 $2.63 Million - $2.93 Million	-25,000 Reduced 24.51%	77,000 $8.67 Million
Q1 2021 May 12, 2021	BUY	$102.3 - $112.62 $2.15 Million - $2.37 Million	21,000 Added 25.93%	102,000 $11 Million
Q4 2020 Feb 12, 2021	BUY	$80.49 - $108.67 $1.37 Million - $1.85 Million	17,000 Added 26.56%	81,000 $8.68 Million
Q3 2020 Nov 13, 2020	BUY	$85.91 - $100.83 $416,663 - $489,025	4,850 Added 8.2%	64,000 $5.61 Million
Q2 2020 Aug 13, 2020	SELL	$73.37 - $98.18 $440,220 - $589,080	-6,000 Reduced 9.21%	59,150 $5.81 Million
Q1 2020 May 12, 2020	BUY	$64.5 - $97.79 $422,475 - $640,524	6,550 Added 11.18%	65,150 $4.96 Million
Q4 2019 Feb 12, 2020	BUY	$72.13 - $90.25 $4.23 Million - $5.29 Million	58,600 New	58,600 $5.19 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dcf Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dcf Advisers, LLC with notifications on news.

Account